Correlation Between GlaxoSmithKline PLC and Vanguard Funds

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Vanguard Funds at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Vanguard Funds into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Vanguard Funds Plc, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Vanguard Funds and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Vanguard Funds. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Vanguard Funds.

Diversification Opportunities for GlaxoSmithKline PLC and Vanguard Funds

0.55
  Correlation Coefficient

Very weak diversification

The 3 months correlation between GlaxoSmithKline and Vanguard is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Vanguard Funds Plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vanguard Funds Plc and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Vanguard Funds. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vanguard Funds Plc has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Vanguard Funds go up and down completely randomly.

Pair Corralation between GlaxoSmithKline PLC and Vanguard Funds

Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to under-perform the Vanguard Funds. In addition to that, GlaxoSmithKline PLC is 3.83 times more volatile than Vanguard Funds Plc. It trades about -0.33 of its total potential returns per unit of risk. Vanguard Funds Plc is currently generating about -0.02 per unit of volatility. If you would invest  553.00  in Vanguard Funds Plc on August 25, 2024 and sell it today you would lose (1.00) from holding Vanguard Funds Plc or give up 0.18% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy95.65%
ValuesDaily Returns

GlaxoSmithKline PLC ADR  vs.  Vanguard Funds Plc

 Performance 
       Timeline  
GlaxoSmithKline PLC ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GlaxoSmithKline PLC ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Vanguard Funds Plc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vanguard Funds Plc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Vanguard Funds is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

GlaxoSmithKline PLC and Vanguard Funds Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GlaxoSmithKline PLC and Vanguard Funds

The main advantage of trading using opposite GlaxoSmithKline PLC and Vanguard Funds positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Vanguard Funds can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vanguard Funds will offset losses from the drop in Vanguard Funds' long position.
The idea behind GlaxoSmithKline PLC ADR and Vanguard Funds Plc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Complementary Tools

Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Volatility Analysis
Get historical volatility and risk analysis based on latest market data